Investors are currently facing key decisions regarding gold allocation. Recent research by reporters at a prominent gold retailer revealed that popular products were sold out due to dual factors: anticipated end-of-month price hikes and promotional activities during the Spring Festival holiday. Despite the conclusion of these promotions, queues of customers persist, with some expressing concerns about potential price increases and opting for early purchases. This gold-buying enthusiasm is mirrored in capital markets, where a "gold feast" is underway. According to the China Gold Association, in 2025, consumption of gold bars and coins in China surpassed that of gold jewelry for the first time. Investors now stand at a crossroads, evaluating options including physical gold, bank accumulation gold products, gold ETFs, and gold stock ETFs to determine the best strategy for participating in this trend.

Institutional investors have conducted research on nearly 240 listed companies in February, with particular focus on investment opportunities in humanoid robotics and related sectors. Wind data indicates that, as of February 26, these companies have attracted significant institutional attention. During a period of high volatility in the A-share market, over half of the researched companies achieved positive returns, with some stocks surging more than 80% since the beginning of the month, significantly outperforming major market indices.

Sales performance among leading automakers showed divergence in January, presenting a pattern of "five increases and five decreases." Following record highs in domestic automobile production and sales exceeding 34 million units in 2025, January 2026 data serves as a critical indicator for the year's industry trajectory. The latest figures from the China Association of Automobile Manufacturers reveal that domestic automobile sales reached 2.346 million units in January 2026. The top ten automakers collectively sold 1.962 million units, accounting for 83.6% of total sales and marking a new high in market concentration, underscoring the "winner-takes-all" Matthew effect.

The brain-computer interface sector is gaining traction, with intensive institutional research conducted this year. By February 26, 80 listed companies in the pharmaceutical and biological industries had undergone institutional surveys. Notably, concept stocks such as Xiangyu Medical, Aipeng Medical, and Meihao Medical attracted multiple institutional investors, with focus areas including product development progress, commercialization status, and future planning. Concurrently, enthusiasm for innovative drugs going global remains strong, with several pharmaceutical companies also receiving institutional attention.